位置:首页 > 蛋白库 > CXB6_HUMAN
CXB6_HUMAN
ID   CXB6_HUMAN              Reviewed;         261 AA.
AC   O95452; B3KQN2; Q5Q1H9; Q5Q1I0; Q5Q1I1; Q5T5U0; Q8IUP0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2003, sequence version 2.
DT   03-AUG-2022, entry version 180.
DE   RecName: Full=Gap junction beta-6 protein;
DE   AltName: Full=Connexin-30;
DE            Short=Cx30;
GN   Name=GJB6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT DFNA3B MET-5.
RX   PubMed=10471490; DOI=10.1038/12612;
RA   Grifa A., Wagner C.A., D'Ambrosio L., Melchionda S., Bernardi F.,
RA   Lopez-Bigas N., Rabionet R., Arbones M., Monica M.D., Estivill X.,
RA   Zelante L., Lang F., Gasparini P.;
RT   "Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3
RT   locus.";
RL   Nat. Genet. 23:16-18(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-139 AND THR-199.
RX   PubMed=10610709; DOI=10.1006/geno.1999.6002;
RA   Kelley P.M., Abe S., Askew J.W., Smith S.D., Usami S., Kimberling W.J.;
RT   "Human connexin 30 (GJB6), a candidate gene for nonsyndromic hearing loss:
RT   molecular cloning, tissue-specific expression, and assignment to chromosome
RT   13q12.";
RL   Genomics 62:172-176(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Corpus callosum;
RA   Enriquez A.D., Scherer S.S.;
RT   "Human connexin30, updated ORF.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thyroid;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-40, AND GENE STRUCTURE.
RC   TISSUE=Hair follicle;
RX   PubMed=15792634; DOI=10.1016/j.gene.2004.12.048;
RA   Essenfelder G.M., Larderet G., Waksman G., Lamartine J.;
RT   "Gene structure and promoter analysis of the human GJB6 gene encoding
RT   connexin 30.";
RL   Gene 350:33-40(2005).
RN   [10]
RP   INVOLVEMENT IN DFNB1B.
RX   PubMed=11807148; DOI=10.1056/nejmoa012052;
RA   del Castillo I., Villamar M., Moreno-Pelayo M.A., del Castillo F.J.,
RA   Alvarez A., Telleria D., Menendez I., Moreno F.;
RT   "A deletion involving the connexin 30 gene in nonsyndromic hearing
RT   impairment.";
RL   N. Engl. J. Med. 346:243-249(2002).
RN   [11]
RP   INVOLVEMENT IN DFNB1B.
RX   PubMed=15994881; DOI=10.1136/jmg.2004.028324;
RA   del Castillo F.J., Rodriguez-Ballesteros M., Alvarez A., Hutchin T.,
RA   Leonardi E., de Oliveira C.A., Azaiez H., Brownstein Z., Avenarius M.R.,
RA   Marlin S., Pandya A., Shahin H., Siemering K.R., Weil D., Wuyts W.,
RA   Aguirre L.A., Martin Y., Moreno-Pelayo M.A., Villamar M., Avraham K.B.,
RA   Dahl H.H., Kanaan M., Nance W.E., Petit C., Smith R.J., Van Camp G.,
RA   Sartorato E.L., Murgia A., Moreno F., del Castillo I.;
RT   "A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found
RT   in trans with mutations in the GJB2 gene (connexin-26) in subjects with
RT   DFNB1 non-syndromic hearing impairment.";
RL   J. Med. Genet. 42:588-594(2005).
RN   [12]
RP   VARIANTS ECTD2 ARG-11 AND VAL-88.
RX   PubMed=11017065; DOI=10.1038/79851;
RA   Lamartine J., Munhoz Essenfelder G., Kibar Z., Lanneluc I., Callouet E.,
RA   Laoudj D., Lemaitre G., Hand C., Hayflick S.J., Zonana J., Antonarakis S.,
RA   Radhakrishna U., Kelsell D.P., Christianson A.L., Pitaval A.,
RA   Der Kaloustian V., Fraser C., Blanchet-Bardon C., Rouleau G.A., Waksman G.;
RT   "Mutations in GJB6 cause hidrotic ectodermal dysplasia.";
RL   Nat. Genet. 26:142-144(2000).
RN   [13]
RP   VARIANT ECTD2 GLU-37.
RX   PubMed=11874494; DOI=10.1046/j.0022-202x.2001.01689.x;
RA   Smith F.J., Morley S.M., McLean W.H.I.;
RT   "A novel connexin 30 mutation in Clouston syndrome.";
RL   J. Invest. Dermatol. 118:530-532(2002).
RN   [14]
RP   VARIANT ARG-59.
RX   PubMed=19416251; DOI=10.1111/j.1365-2133.2009.09137.x;
RA   Nemoto-Hasebe I., Akiyama M., Kudo S., Ishiko A., Tanaka A., Arita K.,
RA   Shimizu H.;
RT   "Novel mutation p.Gly59Arg in GJB6 encoding connexin 30 underlies
RT   palmoplantar keratoderma with pseudoainhum, knuckle pads and hearing
RT   loss.";
RL   Br. J. Dermatol. 161:452-455(2009).
CC   -!- FUNCTION: One gap junction consists of a cluster of closely packed
CC       pairs of transmembrane channels, the connexons, through which materials
CC       of low MW diffuse from one cell to a neighboring cell.
CC   -!- SUBUNIT: A connexon is composed of a hexamer of connexins. Interacts
CC       with CNST (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O95452; Q15125: EBP; NbExp=3; IntAct=EBI-13345609, EBI-3915253;
CC       O95452; Q9BZJ8: GPR61; NbExp=3; IntAct=EBI-13345609, EBI-12808020;
CC       O95452; P26715: KLRC1; NbExp=3; IntAct=EBI-13345609, EBI-9018187;
CC       O95452; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-13345609, EBI-2820517;
CC       O95452; Q5J8X5: MS4A13; NbExp=3; IntAct=EBI-13345609, EBI-12070086;
CC       O95452; Q96IW7: SEC22A; NbExp=3; IntAct=EBI-13345609, EBI-8652744;
CC       O95452; O75396: SEC22B; NbExp=3; IntAct=EBI-13345609, EBI-1058865;
CC       O95452; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-13345609, EBI-18159983;
CC       O95452; A2RU14: TMEM218; NbExp=3; IntAct=EBI-13345609, EBI-10173151;
CC       O95452; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-13345609, EBI-2852148;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cell
CC       junction, gap junction.
CC   -!- DISEASE: Ectodermal dysplasia 2, Clouston type (ECTD2) [MIM:129500]: A
CC       form of ectodermal dysplasia, a heterogeneous group of disorders due to
CC       abnormal development of two or more ectodermal structures such as hair,
CC       teeth, nails and sweat glands, with or without any additional clinical
CC       sign. Each combination of clinical features represents a different type
CC       of ectodermal dysplasia. ECTD2 is an autosomal dominant condition
CC       characterized by atrichosis, nail hypoplasia and deformities,
CC       hyperpigmentation of the skin, normal teeth, normal sweat and sebaceous
CC       gland function. Palmoplantar hyperkeratosis is a frequent feature.
CC       Hearing impairment has been detected in few cases.
CC       {ECO:0000269|PubMed:11017065, ECO:0000269|PubMed:11874494}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Deafness, autosomal recessive, 1B (DFNB1B) [MIM:612645]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner ear,
CC       the nerve pathways to the brain, or the area of the brain that receives
CC       sound information. {ECO:0000269|PubMed:11807148,
CC       ECO:0000269|PubMed:15994881}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Deafness, autosomal dominant, 3B (DFNA3B) [MIM:612643]: A form
CC       of non-syndromic sensorineural hearing loss characterized by a variable
CC       phenotype, ranging from bilateral middle to high frequency hearing loss
CC       to profound sensorineural deafness. Sensorineural deafness results from
CC       damage to the neural receptors of the inner ear, the nerve pathways to
CC       the brain, or the area of the brain that receives sound information.
CC       {ECO:0000269|PubMed:10471490}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the connexin family. Beta-type (group I)
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Connexin-deafness homepage;
CC       URL="http://perelman.crg.es/deafness/";
CC   -!- WEB RESOURCE: Name=Hereditary hearing loss homepage; Note=Gene page;
CC       URL="https://hereditaryhearingloss.org/dominant-genes";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ005585; CAA06611.1; -; Genomic_DNA.
DR   EMBL; AY297110; AAP51162.1; -; mRNA.
DR   EMBL; AK289592; BAF82281.1; -; mRNA.
DR   EMBL; AK075247; BAG52094.1; -; mRNA.
DR   EMBL; AL355984; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08254.1; -; Genomic_DNA.
DR   EMBL; BC038934; AAH38934.1; -; mRNA.
DR   EMBL; AY789474; AAV67951.1; -; mRNA.
DR   EMBL; AY789475; AAV67952.1; -; mRNA.
DR   EMBL; AY789476; AAV67953.1; -; mRNA.
DR   CCDS; CCDS9291.1; -.
DR   RefSeq; NP_001103689.1; NM_001110219.2.
DR   RefSeq; NP_001103690.1; NM_001110220.2.
DR   RefSeq; NP_001103691.1; NM_001110221.2.
DR   RefSeq; NP_006774.2; NM_006783.4.
DR   RefSeq; XP_016875846.1; XM_017020357.1.
DR   RefSeq; XP_016875847.1; XM_017020358.1.
DR   RefSeq; XP_016875848.1; XM_017020359.1.
DR   RefSeq; XP_016875849.1; XM_017020360.1.
DR   AlphaFoldDB; O95452; -.
DR   SMR; O95452; -.
DR   BioGRID; 116018; 15.
DR   CORUM; O95452; -.
DR   IntAct; O95452; 12.
DR   MINT; O95452; -.
DR   STRING; 9606.ENSP00000348521; -.
DR   PhosphoSitePlus; O95452; -.
DR   BioMuta; GJB6; -.
DR   MassIVE; O95452; -.
DR   PaxDb; O95452; -.
DR   PeptideAtlas; O95452; -.
DR   PRIDE; O95452; -.
DR   ProteomicsDB; 50885; -.
DR   Antibodypedia; 6442; 249 antibodies from 29 providers.
DR   DNASU; 10804; -.
DR   Ensembl; ENST00000241124.11; ENSP00000241124.6; ENSG00000121742.19.
DR   Ensembl; ENST00000400065.7; ENSP00000382938.3; ENSG00000121742.19.
DR   Ensembl; ENST00000400066.8; ENSP00000382939.3; ENSG00000121742.19.
DR   Ensembl; ENST00000636852.1; ENSP00000489698.1; ENSG00000121742.19.
DR   Ensembl; ENST00000643121.1; ENSP00000494468.1; ENSG00000121742.19.
DR   Ensembl; ENST00000643211.1; ENSP00000495841.1; ENSG00000121742.19.
DR   Ensembl; ENST00000644283.1; ENSP00000495320.1; ENSG00000121742.19.
DR   Ensembl; ENST00000644667.1; ENSP00000493621.1; ENSG00000121742.19.
DR   Ensembl; ENST00000647029.1; ENSP00000493834.1; ENSG00000121742.19.
DR   Ensembl; ENST00000647243.1; ENSP00000494733.1; ENSG00000121742.19.
DR   GeneID; 10804; -.
DR   KEGG; hsa:10804; -.
DR   MANE-Select; ENST00000647029.1; ENSP00000493834.1; NM_001110219.3; NP_001103689.1.
DR   UCSC; uc001umz.5; human.
DR   CTD; 10804; -.
DR   DisGeNET; 10804; -.
DR   GeneCards; GJB6; -.
DR   GeneReviews; GJB6; -.
DR   HGNC; HGNC:4288; GJB6.
DR   HPA; ENSG00000121742; Tissue enhanced (bone marrow, esophagus, vagina).
DR   MalaCards; GJB6; -.
DR   MIM; 129500; phenotype.
DR   MIM; 604418; gene.
DR   MIM; 612643; phenotype.
DR   MIM; 612645; phenotype.
DR   neXtProt; NX_O95452; -.
DR   OpenTargets; ENSG00000121742; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   Orphanet; 189; Hidrotic ectodermal dysplasia.
DR   Orphanet; 477; KID syndrome.
DR   PharmGKB; PA28699; -.
DR   VEuPathDB; HostDB:ENSG00000121742; -.
DR   eggNOG; ENOG502QWM8; Eukaryota.
DR   GeneTree; ENSGT01030000234513; -.
DR   HOGENOM; CLU_037388_4_1_1; -.
DR   InParanoid; O95452; -.
DR   OMA; PNHAIKE; -.
DR   OrthoDB; 1043502at2759; -.
DR   PhylomeDB; O95452; -.
DR   TreeFam; TF329606; -.
DR   PathwayCommons; O95452; -.
DR   Reactome; R-HSA-190861; Gap junction assembly.
DR   SignaLink; O95452; -.
DR   BioGRID-ORCS; 10804; 13 hits in 1071 CRISPR screens.
DR   ChiTaRS; GJB6; human.
DR   GeneWiki; GJB6; -.
DR   GenomeRNAi; 10804; -.
DR   Pharos; O95452; Tbio.
DR   PRO; PR:O95452; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; O95452; protein.
DR   Bgee; ENSG00000121742; Expressed in upper arm skin and 130 other tissues.
DR   ExpressionAtlas; O95452; baseline and differential.
DR   Genevisible; O95452; HS.
DR   GO; GO:0005884; C:actin filament; IMP:ARUK-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005922; C:connexin complex; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005921; C:gap junction; IMP:ARUK-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IDA:ARUK-UCL.
DR   GO; GO:0048487; F:beta-tubulin binding; IDA:ARUK-UCL.
DR   GO; GO:0005243; F:gap junction channel activity; IDA:ARUK-UCL.
DR   GO; GO:1903763; F:gap junction channel activity involved in cell communication by electrical coupling; IDA:ARUK-UCL.
DR   GO; GO:0008017; F:microtubule binding; IDA:ARUK-UCL.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0042471; P:ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0016264; P:gap junction assembly; IMP:ARUK-UCL.
DR   GO; GO:1990349; P:gap junction-mediated intercellular transport; IDA:ARUK-UCL.
DR   GO; GO:0048839; P:inner ear development; IEA:Ensembl.
DR   GO; GO:0035633; P:maintenance of blood-brain barrier; NAS:ARUK-UCL.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0003163; P:sinoatrial node development; NAS:BHF-UCL.
DR   GO; GO:0055085; P:transmembrane transport; IDA:ARUK-UCL.
DR   Gene3D; 1.20.1440.80; -; 1.
DR   InterPro; IPR000500; Connexin.
DR   InterPro; IPR019570; Connexin_CCC.
DR   InterPro; IPR017990; Connexin_CS.
DR   InterPro; IPR013092; Connexin_N.
DR   InterPro; IPR038359; Connexin_N_sf.
DR   PANTHER; PTHR11984; PTHR11984; 1.
DR   Pfam; PF00029; Connexin; 1.
DR   PRINTS; PR00206; CONNEXIN.
DR   SMART; SM00037; CNX; 1.
DR   SMART; SM01089; Connexin_CCC; 1.
DR   PROSITE; PS00407; CONNEXINS_1; 1.
DR   PROSITE; PS00408; CONNEXINS_2; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Deafness; Disease variant;
KW   Ectodermal dysplasia; Gap junction; Hearing; Membrane;
KW   Non-syndromic deafness; Palmoplantar keratoderma; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..261
FT                   /note="Gap junction beta-6 protein"
FT                   /id="PRO_0000057871"
FT   TOPO_DOM        1..22
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        23..45
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        46..75
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        76..98
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        99..131
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        132..154
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        155..192
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        193..215
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        216..261
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VARIANT         5
FT                   /note="T -> M (in DFNA3B; dbSNP:rs104894414)"
FT                   /evidence="ECO:0000269|PubMed:10471490"
FT                   /id="VAR_008711"
FT   VARIANT         11
FT                   /note="G -> R (in ECTD2; dbSNP:rs104894415)"
FT                   /evidence="ECO:0000269|PubMed:11017065"
FT                   /id="VAR_015696"
FT   VARIANT         37
FT                   /note="V -> E (in ECTD2; dbSNP:rs104894416)"
FT                   /evidence="ECO:0000269|PubMed:11874494"
FT                   /id="VAR_016838"
FT   VARIANT         59
FT                   /note="G -> R (found in one patient with a syndrome
FT                   resembling Vohwinkel and Bart-Pumphrey syndromes)"
FT                   /evidence="ECO:0000269|PubMed:19416251"
FT                   /id="VAR_057960"
FT   VARIANT         88
FT                   /note="A -> V (in ECTD2; dbSNP:rs28937872)"
FT                   /evidence="ECO:0000269|PubMed:11017065"
FT                   /id="VAR_015697"
FT   VARIANT         139
FT                   /note="S -> G"
FT                   /evidence="ECO:0000269|PubMed:10610709"
FT                   /id="VAR_022424"
FT   VARIANT         159
FT                   /note="N -> S (in dbSNP:rs35277762)"
FT                   /id="VAR_048825"
FT   VARIANT         199
FT                   /note="S -> T (in dbSNP:rs111033338)"
FT                   /evidence="ECO:0000269|PubMed:10610709"
FT                   /id="VAR_022425"
FT   CONFLICT        11
FT                   /note="G -> E (in Ref. 9; AAV67951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        124
FT                   /note="Q -> H (in Ref. 1; CAA06611)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   261 AA;  30387 MW;  394A2D97E08EEB43 CRC64;
     MDWGTLHTFI GGVNKHSTSI GKVWITVIFI FRVMILVVAA QEVWGDEQED FVCNTLQPGC
     KNVCYDHFFP VSHIRLWALQ LIFVSTPALL VAMHVAYYRH ETTRKFRRGE KRNDFKDIED
     IKKQKVRIEG SLWWTYTSSI FFRIIFEAAF MYVFYFLYNG YHLPWVLKCG IDPCPNLVDC
     FISRPTEKTV FTIFMISASV ICMLLNVAEL CYLLLKVCFR RSKRAQTQKN HPNHALKESK
     QNEMNELISD SGQNAITGFP S
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025